SamYoung Chemical Co.,Ltd

KRX:003720.KS

4155 (KRW) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 122,586.708147,748.013133,269.776117,657.777111,144.083102,947.885100,355.12113,635.691126,120.581159,393.666183,823.825215,675.811241,019.879217,499.666202,330.929195,931.786136,678.299
Cost of Revenue 104,342.759130,133.615115,305.525101,807.25199,749.88996,768.356101,253.677107,731.958125,269.121153,596.807172,307.307189,314.535195,268.401186,496.149178,211.605177,385.13131,914.556
Gross Profit 18,243.94917,614.39817,964.25215,850.52611,394.1956,179.528-898.5575,903.732851.465,796.85911,516.51926,361.27745,751.47831,003.51724,119.32418,546.6564,763.743
Gross Profit Ratio 0.1490.1190.1350.1350.1030.06-0.0090.0520.0070.0360.0630.1220.190.1430.1190.0950.035
Reseach & Development Expenses 2,826.5553,491.8953,359.4363,001.4252,342.322,729.0812,653.161047700000000
General & Administrative Expenses 467.277440.425425.933502.485500.546391.358591.246701.9761,141.6111,676.9341,923.6942,238.6582,622.8533,492.471,437.7731,887.91,106.753
Selling & Marketing Expenses 5,538.3587,879.9547,088.0026,093.3436,051.446,450.9776,267.6446,936.9866,699.4949,849.56810,70811,290.44110,834.34910,639.4078,709.2639,069.2996,811.234
SG&A 8,997.1418,320.3797,513.9356,595.8286,551.9866,842.3356,858.897,638.9627,841.10511,526.50212,631.69413,529.09913,457.20214,131.87710,147.03610,957.1997,917.987
Other Expenses -351.2664,762.8254,499.0724,936.2233,405.631-126.685-1,253.938-1,569.161217.743-2,415.923-122.847-74.1555,395.205312.723-537.538-199.334-44.108
Operating Expenses 12,174.96216,575.09915,372.44314,533.47612,299.93712,454.1612,890.66312,255.34813,315.66916,727.0919,109.41719,508.2618,852.40719,566.50313,718.82214,515.87410,870.225
Operating Income 6,068.9871,962.9912,591.8081,317.05-709.634-6,274.632-13,789.221-6,351.616-12,464.209-10,930.231-7,592.8996,853.01727,236.15611,437.01110,400.5024,030.78-6,106.48
Operating Income Ratio 0.050.0130.0190.011-0.006-0.061-0.137-0.056-0.099-0.069-0.0410.0320.1130.0530.0510.021-0.045
Total Other Income Expenses Net 6,657.513-579.665236.179-613.664-1,036.342-1,461.984-16,041.119-4,569.819-1,208.648-8,734.823-616.844723.622103.221-1,017.805-1,092.071-2,433.432-1,507.446
Income Before Tax 12,726.51,383.3262,827.987703.386-1,745.976-7,736.616-29,830.339-10,921.434-13,672.857-19,665.054-8,209.7427,576.63827,002.29210,419.2099,308.4311,597.35-7,613.928
Income Before Tax Ratio 0.1040.0090.0210.006-0.016-0.075-0.297-0.096-0.108-0.123-0.0450.0350.1120.0480.0460.008-0.056
Income Tax Expense -1,283.889296.559-803.767-447.472146.66175.6461,974.241-177.445-876.961-2,443.247268.0422,497.9038,266.9423,349.3931,642.1224,815.503-923.443
Net Income 18,633.4951,086.7673,481.1291,150.858-1,892.637-6,889.181-21,470.565-7,000.097-11,549.62-16,086.792-6,881.9656,105.14620,097.4028,996.1587,666.309-3,218.153-6,690.485
Net Income Ratio 0.1520.0070.0260.01-0.017-0.067-0.214-0.062-0.092-0.101-0.0370.0280.0830.0410.038-0.016-0.049
EPS 558.2331.98102.4233.86-55.69-203-632-206-340-473-202180591278.2249-107.1-224.6
EPS Diluted 558.2331.98102.4233.86-55.69-203-632-206-340-473-202180591278.2249-107.1-224.6
EBITDA 12,736.7078,717.9879,775.9738,594.46,595.96930.03-4,740.9934,094.0552,535.994-2,260.573,145.6413,468.80235,588.93821,228.86120,493.84114,689.9937,000.255
EBITDA Ratio 0.1040.0590.0730.0730.0590.009-0.0470.0360.02-0.0140.0170.0620.1480.0980.1010.0750.051